DBC2 gene is silenced by promoter methylation in bladder cancer

21Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Deletions at 8p are frequent in many human cancers and represent a genetic marker associated with a more aggressive tumor phenotype. Previous mutational analysis of DBC2 (deleted in breast cancer 2), a tumor suppressor gene located in the region of loss of heterozygosity (LOH) on 8p21, failed to show a high frequency of mutation linked to low expression in bladder cancer. Promoter hypermethylation may be an alternative mechanism of inactivation of the second allele. We detected the methylation status and expression of the DBC2 gene in 75 bladder cancer samples and 57 corresponding normal tissues. Aberrant methylation and down-regulation of DBC2 were observed preferentially in tumor samples (P < 0.05), and the expression changes were associated with methylation (P < 0.05). These findings, together with the previously mutation reports, suggest that aberrant methylation in DBC2 promoter may be responsible for the expression loss of DBC2 expression in bladder cancer and this hypermethylation event could play a crucial role in the early stage of bladder tumorigenesis. © 2008 Elsevier Inc. All rights reserved.

Cite

CITATION STYLE

APA

Shi, Y., Chen, J. Y., Yang, J., Li, B., Chen, Z. H., & Xiao, C. G. (2008). DBC2 gene is silenced by promoter methylation in bladder cancer. Urologic Oncology: Seminars and Original Investigations, 26(5), 465–469. https://doi.org/10.1016/j.urolonc.2007.08.009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free